Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01933035 · ClinicalTrials.gov registry record
Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.
A clinical trial, sponsored by Beth Israel Medical Center.
- Completed
- Registry status
- 50
- Enrollment target
NCT01933035: Completed study, sponsored by Beth Israel Medical Center.
NCT01933035 is a clinical trial that has completed, run by Beth Israel Medical Center. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01933035 has completed, sponsored by Beth Israel Medical Center.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
To utilise extended platelet parameters in order to individuate Immune Thrombocytopenia (ITP) from hypo-proliferative causes of thrombocytopenia. To develop the clinical potential of the extended platelet parameters as they pertain to distinguishing different causes of thrombocytopenia from one another. To test the hypothesis that mean platelet component (MPC) and mean platelet mass (MPM) might distinguish between thrombocytopenia related to bone marrow dysfunction and immune mediated destruction of platelets.
Interventions
- OTHER Immune Thrombocytopenics
- OTHER Hypo-proliferative thrombocytopenics
- OTHER Control Population
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-10 |
What the finished NCT01933035 record still lists
NCT01933035 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Immune Thrombocytopenics is the first listed.
NCT01933035 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01933035 about?
NCT01933035 is a clinical study titled "Extended Platelet Parameters as a Means to Differentiate Immune Thrombocytopenia From Hypo-proliferative Thrombocytopenias.". To utilise extended platelet parameters in order to individuate Immune Thrombocytopenia (ITP) from hypo-proliferative causes of thrombocytopenia. To develop the clinical potential of the extended platelet parameters as they pertain to distinguishing different causes of thrombocytopenia from one ano...
What is the current status of trial NCT01933035?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2013-10. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01933035?
The interventions under investigation include: Immune Thrombocytopenics (OTHER), Hypo-proliferative thrombocytopenics (OTHER), Control Population (OTHER).
Who is sponsoring clinical trial NCT01933035?
This trial is sponsored by Beth Israel Medical Center, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia